| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 271.25▼ | 271.63▼ | 271.27▼ | 272.69▼ | 273.51▼ |
| MA10 | 271.38▼ | 271.76▼ | 272.58▼ | 270.52▲ | 284.39▼ |
| MA20 | 271.76▼ | 272.80▼ | 273.68▼ | 272.84▼ | 285.95▼ |
| MA50 | 271.73▼ | 273.89▼ | 271.52▼ | 285.68▼ | 292.33▼ |
| MA100 | 273.00▼ | 271.16▲ | 272.37▼ | 286.05▼ | 298.88▼ |
| MA200 | 273.83▼ | 272.46▼ | 280.43▼ | 291.70▼ | 301.54▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.062▼ | -0.216▼ | -0.508▼ | 0.817▲ | -1.871▼ |
| RSI | 41.987▼ | 38.171▼ | 43.720▼ | 41.078▼ | 40.456▼ |
| STOCH | 17.728▼ | 30.928 | 22.818 | 66.284 | 14.385▼ |
| WILL %R | -89.873▼ | -77.690▼ | -81.198▼ | -44.260 | -82.686▼ |
| CCI | -77.507 | -72.652 | -93.975 | -6.636 | -92.408 |
|
Monday, December 01, 2025 02:58 PM
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
|
|
Monday, December 01, 2025 01:29 PM
Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC ...
|
|
Monday, December 01, 2025 09:36 AM
What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 6% in the afternoon session after the U.S. Food and Drug Administration (FDA) approved a competing blood-based test ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/12/25 | 273.21 | 273.21 | 270.08 | 271.21 | 277,241 |
| 01/12/25 | 273.025 | 275.20 | 270.97 | 271.15 | 1,105,036 |
| 28/11/25 | 273.19 | 276.13 | 273.10 | 274.54 | 382,094 |
| 26/11/25 | 271.19 | 275.665 | 271.02 | 274.21 | 922,785 |
| 25/11/25 | 270.77 | 275.07 | 270.77 | 272.33 | 877,465 |
| 24/11/25 | 270.40 | 270.40 | 266.23 | 269.17 | 1,879,139 |
| 21/11/25 | 267.12 | 272.69 | 267.03 | 269.51 | 1,473,284 |
| 20/11/25 | 266.87 | 267.80 | 262.47 | 265.45 | 1,125,661 |
| 19/11/25 | 272.03 | 273.55 | 265.19 | 266.16 | 1,323,551 |
| 18/11/25 | 269.52 | 271.63 | 266.91 | 271.50 | 873,529 |
|
|
||||
|
|
||||
|
|